FdaApplication
ANDA 216719
Identifiers
- fda_app_no: ANDA216719
Properties
| Property | Value |
|---|---|
| applicant_name | PADAGIS ISRAEL PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2025-04-24 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | 8MG/SPRAY | SPRAY;NASAL |
1 product